Prevalence of latent tuberculosis infection in healthcare workers at a hospital in Naples, Italy, a low-incidence country by unknown
RESEARCH Open Access
Prevalence of latent tuberculosis infection
in healthcare workers at a hospital in
Naples, Italy, a low-incidence country
Monica Lamberti1*, Mariarosaria Muoio1, Antonio Arnese1, Sharon Borrelli1, Teresa Di Lorenzo1,
Elpidio Maria Garzillo1, Giuseppe Signoriello2, Stefania De Pascalis2, Nicola Coppola2 and Albert Nienhaus3
Abstract
Background: Healthcare workers (HCWs) are at higher risk than the general population of contracting tuberculosis
(TB). Moreover, although subjects with latent TB infection (LTBI) are asymptomatic and are not infectious, they may
eventually develop active disease. Thus, a fundamental tool of TB control programs for HCWs is the screening and
treatment of LTBI.
Methods: From January 2014 to January 2015, hospital personnel at Azienda Ospedaliera Universitaria, Naples, Italy,
were screened for TB. To this end, a tuberculin skin test (TST) was administered as an initial examination, unless
when contraindicated, in which case the QuantiFERON® TB-Gold (QFT) assay was performed. Moreover, QFT was
carried out on all TST-positive cases to confirm the initial result.
Results: Of 628 personnel asked to participate, 28 (4.5%) denied consent, 533 were administered TST as the
baseline examination, and 67 were tested only with QFT. In the TST group, 73 (13.2%) individuals were found
positive, 418 (78.4%) were negative, and 42 (7.9%) were absent for the reading window; QFT confirmed the
result in 39 (53.4%) TST-positive individuals. In the QFT-only group, 44 (65.7%) individuals were found positive.
All TST- and/or QFT-positive subjects were referred for chest X-ray and examination by an infectious diseases
specialist. None were found to have active TB, and were thus diagnosed with LTBI.
Conclusions: Although Italy is a low-incidence country regarding TB, our findings suggest that the prevalence
of LTBI in HCWs may be relatively high. As a result, active screening for TB and LTBI is needed for these workers.
Keywords: Tuberculosis, Tuberculin skin test, Healthcare workers, Quantiferon test, Health surveillance, Occupational
exposure
Background
Tuberculosis (TB) is a major health problem worldwide.
The World Health Organization estimates that in 2013
there were 9.0 million new cases and 1.5 million TB-
related deaths [1]. Compounding this problem is
multidrug-resistant TB, which globally was estimated to
affect 3.5% of new TB cases in 2013. Although Italy is
considered a low-incidence country for TB-the number
of estimated new cases in 2013 was less than 10/100,000
inhabitants [1] – the disease is still considered a risk
owing to abandonment of vaccination campaigns, wide
diffusion of primary and secondary immunosuppression,
and influx of immigrants [2, 3].
Compared with the general population, healthcare
workers (HCWs) have a higher risk of contracting a TB
infection on account of increased exposure to individ-
uals in a contagious phase of the disease, inadequate use
of personal protective equipment, and their specific
working conditions, such as having to carry out activities
in poorly ventilated areas [4, 5]. Median annual inci-
dences of active TB among HCWs in countries with low,
intermediate, and high rates of TB are 67, 91, and 1,180
per 100,000 persons, respectively [6].
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The majority of active TB cases in HCWs occur
when the risk of TB infection is underestimated and
control programs are lacking. Thus, improving the
understanding of TB transmission and adopting ef-
fective control measures have been recommended to
reduce the risk of nosocomial infection [6, 7]. In
addition, a fundamental tool for TB control programs
is the screening and treatment of latent TB infection
(LTBI). This is strongly recommended in many coun-
tries, including Italy. Indeed, although individuals with
LTBI do not show symptoms of TB and are not in-
fectious, about 10% are at risk of developing active
disease and becoming infectious during the course of
their lifetime [1]. A recent review estimated the me-
dian annual risk of LTBI among HCWs to be 2.9% in
countries with a low incidence of TB and 7.2% in
countries with a high incidence [6].
The main purpose of the current study was therefore
to evaluate the prevalence of active TB and LTBI among
hospital personnel operating in a context of low endem-
icity, and to assess possible associations between the
outcome of the screening tests and epidemiological
variables.
Methods
From January 2014 to January 2015, a TB screening pro-
gram was carried out at Azienda Ospedaliera Universi-
taria, Naples, Italy, a hospital with a risk classifiable as
“low” according to CDC guidelines (i.e., <6TB patients/
year in a setting with ≥200 in-patient beds) [8]. The
Italian Society of Occupational Medicine recommends
to carry out a tuberculin skin test (TST) every 6 years in
healthcare structures classified as “very low” risk, every 2
years in “low” risk structures, every year if the risk is
“medium”, and twice-yearly when the risk is “high” [9].
All hospital personnel, including physicians, surgeons,
nurses, midwives, physiotherapists, laboratory techni-
cians, radiographers, ambulance drivers, orderlies, and
maintenance workers employed at the institution during
the study period were asked to take part in this cross-
sectional study. A pre-coded questionnaire on demo-
graphics, work (time in healthcare employment, type of
job conducted, workplace frequented), and medical his-
tory (previous exposure to TB, TB vaccination status)
was filled in by each participant.
The surveillance program required a TST as the base-
line examination. The test was performed and assessed
by trained personnel following standard procedures. In
brief, 0.1 ml (2 TU) of the purified protein derivative
RT23 (Statens Serum Institute, Copenhagen, Denmark)
was injected intradermally on the volar side of the fore-
arm of participants and read 48 to 72 h later. In accord-
ance with national guidelines, a positive TST was
defined as an induration measuring ≥10 mm [10–12].
Since vaccination data was either not available or in-
complete for some participants, all TST-positive cases
were then tested also with the QuantiFERON® TB-Gold
(QFT) kit (Cellestis, Carnegie, Australia), a second-
generation test based on an interferon-gamma release
assay (IGRA) [13]. Participants with secondary immuno-
deficiency or a history of allergy were offered the oppor-
tunity to take the QFT test as their baseline examination
in order to remove any possible risk of an allergic-
type reaction [6]. Pregnant participants were also
asked to take only this test because we wished to
avoid multiple diagnostic exams in these woman,
despite there being no evidence in the literature that
adverse reactions to the Mantoux test can influence
the course of pregnancy [6].
For the QFT test, 1 ml of whole blood was
aliquoted into each of three QFT tubes, containing
either TB-specific antigen (ESAT-6, CFP-10, and
TB7.7), no antigen (negative control), or mitogen
antigen (positive control), and incubated at 37 °C
overnight before centrifugation, as recommended by
the manufacturer’s protocol. Interferon-gamma con-
centration was then measured by ELISA: a reading
≥0.35 IU/ml (TB antigens minus negative control)
was considered positive [14, 15].
All TST- and/or QFT-positive cases were referred for
chest radiography and carefully examined by an infec-
tious diseases specialist. We elected to suspect active TB
infection in the presence of clinical symptoms such as
cough, weight loss, fever, nocturnal sweating, tiredness,
and/or X-ray suggestive of TB, and to confirm the
disease by the presence of TB pathogens in sputum
culture; a diagnosis of LTBI was given to test-positive
participants not presenting with clinical or radiographic
signs of active TB [2].
This cross-sectional study was performed in compli-
ance with the Declaration of Helsinki and current
healthcare standards, according to the recommendations
of the Italian Ministry of Health [11]. All participants
were informed by a physician on the rationale and aims,
and written informed consent was obtained. According
to Italian legislation concerning guidelines on observa-
tional studies, ethical approval for conducting this study
was unnecessary, so we did not require formal approval
by local institutional review boards [16]. Personal infor-
mation regarding the enrolled subjects was protected
according to Italian law [17].
Statistical analysis of the data was performed using
SPSS v.17.0 software. Continuous variables are given as
mean and standard deviation, and categorical variables
as absolute and relative frequencies. Differences in
means were evaluated by unpaired Student t-test, and
the Chi-squared test was applied to categorical variables.
Odds ratio (OR), with a 95% confidence interval (CI),
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was estimated by a logistic regression model to evaluate
the presence of LTBI, with sex, age, work seniority, and
type of employment as covariates. A p-value of <0.05
was considered statistically significant.
Results
Six hundred twenty-eight personnel were asked to
participate in the study: 28 (4.5%) denied consent and 42
(6.7%) failed to complete it (Fig. 1). The main demo-
graphic and epidemiological characteristics of the
remaining participants are listed in Table 1: all were
Italian; mean age was ~56 years; there was a slightly
higher prevalence of males; mean time in employment
was ~25 years; and almost half were nursing staff, with
nursing and medical staff comprising over 93% of all
personnel tested. No one reported knowledge of being
exposed to TB outside the hospital and all were HIV-
negative.
The baseline examination was the TST for 533 of the
participants and the QFT assay for the remaining 67. Of
the former, 73/533 (13.7%) were positive to the test, 418/
533 (78.4) were negative, and 42/533 (7.9%) were absent
during the reading window and were asked to repeat the
test within 90 days. However, the evaluations of the
retested participants occurred after January 2015, so this
data was excluded from the current study. No adverse
loco-regional or systemic allergic reactions were encoun-
tered. All the TST-positive subjects were then given the
QFT assay: a positive result was confirmed in 39/73
(53.4%) cases.
The QFT assay was administered as the baseline exam-
ination to 52 participants with a positive history of drug
allergy, to 10 pregnant women, and to 5 individuals tak-
ing immunosuppressive drugs: none reported a history
of positivity to TST. Of these 67, 44 (65.7%) resulted
positive and 23 (34.3%) negative.
All the 83 participants found positive with QFT (i.e.,
the 39 individuals positive at both tests plus the 44 indi-
viduals positive at QFT as the baseline assay) were given
a chest X-ray and a careful examination by an infectious
diseases specialist. Clinical and radiographic signs of ac-
tive TB were excluded for all, so they were diagnosed
with LTBI. In addition, although the 34 TST-positive/
QFT-negative participants were strongly suspected of
being falsely positive to the baseline TST (they were
unable to provide documented information on TB
vaccination or possible contact with non-TB mycobac-
teria [15]), we decided to refer them to chest X-ray and
specialist examination: no evidence of TB was found in
any of these subjects either.
Table 2 gives the demographic characteristics of the
study population stratified for the presence of LTBI
Fig. 1 Study flow diagram and results. Abbreviations: TST tuberculin skin test, QTF QuantiFERON® TB-Gold assay
Lamberti et al. Journal of Occupational Medicine and Toxicology  (2016) 11:53 Page 3 of 7
as diagnosed in all QFT-positive participants. Of these
personnel with LTBI, over half were nursing staff;
medical staff also accounted for a large percentage of
LTBI cases, whereas laboratory technicians and other
categories of workers made up only a very small frac-
tion of this group. No statistical differences were
found for sex, age, work seniority, or type of employ-
ment between the participants with and without LTBI
or between those taking TST or QFT as the baseline
examination. This held true also when we added the
data of the 34 TST-positive/QTF-negative participants
(Additional file 1: Table S1). Univariate and multivari-
ate analysis did not identify a demographic factor as-
sociated with LTBI (Tables 2 and 3, Additional file 2:
Table S2).
Finally, all personnel with LTBI were referred for
chemoprophylaxis. Only 6 subjects adhered to the regi-
men and follow-up procedure.
Discussion
Although Italy is considered a country with a low inci-
dence of TB [1, 13], our study identified a relatively high
prevalence (20.9%) of LTBI in the personnel of one hos-
pital, confirming that the risk of TB among HCWs is
higher than that observed in the general population [7].
Indeed, a recent meta-analysis reported that, globally,
the risk faced by HCWs of contracting TB is consistently
higher than of the general population, indicating TB as
an occupational disease [7].
In the present study, no case of active TB was
encountered. In other reports on HCWs conducted in
Italy and other low-incidence countries, the preva-
lences of TB and LTBI varied depending on the coun-
try and the type of population sample studied. For
example, Franchi and colleagues evaluated 1,755
HCWs in Italy in 2004, diagnosing LTBI in 6% of
cases [18]; in a study conducted in France (a low-
incidence country with 5.2 cases of TB per 100,000
inhabitants in 2006), 18.9% of 148 HCWs had a posi-
tive IGRA result [19]: and in a study on 134 HCWs
in Spain (another low-incidence country), the peva-
lence of LTBI was 11.2% [20]. By contrast, a study on
2,884 hospital workers in Portugal (a high-incidence
country, with 32 cases/100,000/year) reported a very
high prevalence of LTBI (i.e., 29.5%) [21]. However, a
Table 1 Demographic and clinical characteristics of the hospital
personnel completing the study
n (%)a
Subjects completing the screeningb 558
Age, years (mean ± SD) 56.1 ± 8
Males 324 (58.2)
Work category
• medical staff 246 (44.1)
• nursing staff 274 (49.1)
• laboratory staff 25 (4.5)
• otherc 13 (2.3)
Workplace frequented
• medical wards 220 (39.4)
• surgical wards 171 (30.6)
• otherd 167 (30)
Years in employment (mean ± SD) 24.8 ± 9.8
TST as baseline examination 491 (88)
• positive 73 (14.8)
• negative 418 (85.2)
QTF as baseline examination 67 (12)
• positive 44 (65.7)
• negative 23 (34.3)
LTBIe 117 (20.9)
Active tuberculosis 0
Abbreviations: TST tuberculin skin test, QTF QuantiFERON® TB-Gold assay,
LTBI latent tuberculosis infection
avalues expressed as absolute frequency (percentage), unless otherwise stated
b28 subjects denied consent and 42 participants were absent during the TST
reading window
cphysiotherapists, orderlies, ambulance drivers, maintenance workers
dintensive care, clinical pathology, occupational medicine, audiology,
radiology, microbiology
eas diagnosed for all individuals found positive at either TST or QFT
Table 2 Univariate analysis for demographic, epidemiological
and occupational characteristics of the hospital personnel






n 83 475 0.47
Age, years (mean ± SD) 56.1 ± 7.2 56.1 ± 8.1 0.19
Males 45 (13.9) 279 (86.1) 0.51
Females 38 (16.2) 196 (83.8)
Work category
• medical staff 36 (14.6) 210 (85.4) 0.45
• nursing staff 44 (16.1) 230 (83.9)
• laboratory staff 1 (4) 24 (96)
• otherc 2 (15.4) 11 (84.6)
Workplace frequented
• medical wards 33 (15) 187 (85) 0.35
• surgical wards 29 (17) 142 (83)
• otherd 21 (12.8) 146 (87.2)
Years in employment
(mean ± SD)
24.1 ± 1.0 24.9 ± 0.4 0.45
Abbreviations: LTBI latent tuberculosis infection, TST tuberculin skin test,
QTF QuantiFERON® TB-Gold assay
aas diagnosed for TST+/QFT+ and QFT+-only participants
bvalues expressed as absolute frequency (percentage), unless otherwise stated
cphysiotherapists, orderlies, ambulance drivers, maintenance workers
dintensive care, clinical pathology, occupational medicine, audiology,
radiology, microbiology
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2005 meta-analysis reported that the prevalence of
LTBI in HCWs ranged 5–55% in high-income coun-
tries [22].
The 20.9% prevalence of LTBI observed in our study,
which represents an intermediate value compared with
previous studies, can be explained, at least in part, by
our HCW population’s relatively high mean age and
number of years in work. Indeed, the prevalences of
LTBI and TB in HCWs are also dependent on the time
that the workers are potentially exposed to the pathogen
and, thus, on those two variables. For example, in a
study on 2,028 HCWs in Germany (a low-incidence
country), the prevalence of LTBI increased with the dur-
ation of employment, going from 5.4% in the subgroup
with less than 5 years of employment, to 12.7% in those
with more than 20 years in the healthcare sector; more-
over, age was found to be the most important risk factor
linked to a positive IGRA result (>55 years; OR: 14.7;
95% CI: 5.1–42.1) [23]. Both mean age and years of
employment of the personnel enrolled in the present
study (56.1 ± 8 and 24.8 ± 9.8 years) were higher than in
the HCWs enrolled by Franchi and colleagues (39 ± 9
and 13 ± 8 years), who reported a much lower preva-
lence of LTBI [18]. The association between age and the
prevalence of LTBI is also confirmed by data collected
on healthcare students. In our recent study on under-
graduate and postgraduate healthcare students in Italy
(mean age: 25.8 ± 5.3 years), LTBI was diagnosed in only
35 of the 3,331 individuals tested (i.e., 1.05%) [24].
Comparable findings were reported by Durando and
colleagues, who found a very low prevalence (0.5%) of
LTBI in 881 Italian undergraduate students (mean age:
23.6 ± 3.1 years) [25].
Apart from age and years of employment, other factors
that have been identified as associated with LTBI in
HCWs are male gender, being born in a high-incidence
country, prior exposure to TB, and a previous positive
TST result. For example, Franchi and colleagues found
that TST reactivity correlated with age (≥47 years) and
the male gender [18]; Durando and colleagues reported
an association with being born in a country with a high
incidence of TB [25]; and a study on German HCWs
identified associations with being foreign-born (OR:
1.99; 95% CI: 1.4–2.8), having TB in the individual’s own
history (OR: 4.96; 95% CI: 1.99–12.3), and a having a
previous positive TST result (OR: 3.5; 95% CI: 2.4–4.98)
[23]. However, in the present study on Italian-born
HCWs of relatively high age and years of employment,
we did not identify any factor associated with LTBI.
The limitations of this study are principally related to
the cross-sectional design used, the lack of a control
group and the relatively low number of subjects evalu-
ated. Moreover, a single testing procedure was used,
with a second test (namely an IGRA) systematically car-
ried out only in the event of a positive TST or in sub-
jects that did not want a skin test. In our experience,
TST is safe and can be used widely (we found no in-
stance of loco-regional or systemic allergic reactions);
our decision to use IGRA as a second-level examination
only in subjects found positive upon TST was aimed at
optimizing costs and increasing the level of diagnostic
accuracy [26]. However, both tests have their drawbacks:
TST has technical limitations in that it can produce
results that are hard to interpret and tends to gener-
ate a significant number of false positives [27–30];
IGRA is more specific and has a sensitivity that is at
least identical to that of TST [20, 31, 32], but it is
more expensive and is difficult to assess around the
cut-off value. Although, the 34 TST-positive but
IGRA-negative subjects in our study would normally
be considered as having been infected by M. tubercu-
losis, we strongly suspected they represented false
positives caused, for example, by contact with non-TB
mycobacteria [15, 33]; indeed, these individuals were
not able to provide us with documented data on TB
vaccination. We nevertheless consider it correct to
use TST as a baseline exam, especially in a country
like Italy where the prevalence of BCG vaccination is
low [34, 35].
Conclusions
Although Italy is considered a low-incidence country for
TB, our data suggest that the prevalence of LTBI in
HCWs may be high, especially in older healthcare
personnel with a longer history of employment in the
sector. In this epidemiological context, active screening
for TB and LTBI is advised.
Table 3 Multivariate analysis for demographic, epidemiological
and occupational characteristics of the hospital personnel
completing the study stratified for LTBIa
Variable OR 95% CI p-value
Female vs Male 1.22 0.75–2.00 0.42
Age 1.02 0.98–1.07 0.35
Years of employment 0.97 0.94–1.01 0.18
Type of employment
• nursing vs medical 1.41 0.74–2.71 0.30
• laboratory vs medical 0.34 0.04–2.73 0.31
• otherb vs medical 1.72 0.33–8.95 0.52
Workplace
• surgery vs medical wards 1.23 0.71–2.13 0.46
• otherc vs medical wards 0.81 0.44–1.51 0.51
Abbreviations: LTBI latent tuberculosis infection, OR odds ratio,
CI confidence interval
aas diagnosed for TST+/QFT+ and QFT+-only participants
bphysiotherapists, orderlies, ambulance drivers, maintenance workers
cintensive care, clinical pathology, occupational medicine, audiology,
radiology, microbiology
Lamberti et al. Journal of Occupational Medicine and Toxicology  (2016) 11:53 Page 5 of 7
Additional files
Additional file 1: Table S1. Demographic, epidemiological and
clinical characteristics of the hospital personnel completing
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